[O-20] Oral Session 20
Myopathy・Neuromuscular junction disorders 2 E

[O-20-2] Suitable indications of eculizumab for patients with refractory generalized myasthenia gravis

^○Munenori Oyama¹, Kensuke Okada¹, Masayuki Masudai², Yuko Shimizu³, Kazumasa Yokoyama⁴, Akiyuki Uzawa⁶, Naoki Kawaguchi⁵, Ryotaro Ikeguchi¹, Yukiko Ozawa⁷, Jin Nakahara¹, Hitoshi Aizawa², Kitagawa Kazuo³, Nobutaka Hattori⁴, Satoshi Kuwabara⁶, Murai Hiroyuki⁷, Shigeaki Suzuki¹ (1.Department of Neurology, Keio University School of Medicine, Japan, 2.Department of Neurology, Tokyo Medical University Hospital, 3.Department of Neurology, Tokyo Women's Medical University School of Medicine, 4.Department of Neurology, Jntendo University School of Medicine, 5.Department of Neurology, Neurology Chiba Clinic, 6.Department of Neurology, Graduate School of Medicine, Chiba University, 7.Department of Neurology, School of Medicine, International University of Health and Welfare)